KVUE — Kenvue Inc.

Kenvue Inc. (KVUE) is a household & personal products company listed on NYSE. It is led by Kirk L. Perry, based in 1 Kenvue Way, Summit, NJ, United States, 07901, with about 21,780 employees. Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Latest reported KVUE revenue for 2025-09-28 was $3.76B. Net income was $398.0M. Revenue was down 2.0% from 2025-06-29 to 2025-09-28. KVUE currently screens at market cap $34.58B and trailing P/E 21.4.

Use this KVUE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the KVUE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the KVUE SEC filings page. Lician reads the product cache first so this HTML stays unique to Kenvue Inc. even when a live quote feed is slow.